课题基金 / 基金详情

Training Program for Applied Research and Development in Genomic Medicine

Training Program for Applied Research and Development in Genomic Medicine
基因组医学应用研究与开发培训计划
批准号:
10627222
负责人:
Julio David Duarte
金额:
$55.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-01-01 至 2028-04-30

项目摘要

项目成果

Julio David Duarte的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Healthcare professionals, genomic scientists, and numerous other stakeholders are embracing the advances in healthcare that are possible, and with increasing frequency are being delivered, through approaches that employ genomics to improve care and patient outcomes. To ensure that we can continue to expand upon and deliver the full potential of such an approach requires a highly qualified cadre of clinician-scientists, scientists, and clinicians working collaboratively to advance discoveries and implementation in genomic medicine. This proposal for continuation of our post-doctoral genomic medicine training program, “Program for Applied Research and Development in Genomic Medicine or PARADIGM,” leverages our successes and lessons learned from the first cycle of funding to: 1) refine an integrated training program in genomic medicine, which includes didactic, research, clinical, and professional development activities; 2) recruit promising junior investigators and train them using an interprofessional and interdisciplinary mentoring approach; and 3) evaluate the PARADIGM training program for achievement of learning objectives, success, and long-term productivity and career progress of trainees. This training program for MDs, PharmDs, PhDs, and other clinical specialists at the doctoral level is based on four premises: 1) Genomic medicine must be advanced by a cadre of clinicians and PhD scientists from a variety of specialty areas; 2) a team approach is essential; 3) genomic medicine will require a diverse workforce of leaders; 4) the University of Florida is an ideal environment for this training. To train individuals to meet these needs, PARADIGM will provide a multi-year, integrated, multidisciplinary program comprised of four major components: 1) a Didactic component of required and optional coursework; 2) a Mentored Research component involving a defined research project under the mentorship of an accomplished genomic medicine scientist and clinician; 3) a Clinical Genomic Medicine component that integrates trainees into the genomic medicine clinical practice setting; and 4) a Professional Development component including training in research integrity; administrative, fiscal and regulatory training; and grant-writing skills. Training across these four components will be tailored to the experience and needs of each trainee, but will be concentrated in three cores of expertise at UF: pharmacogenomics, cancer genomics, and disease susceptibility genetics/genomics. The program will be led by two highly accomplished leaders in the field together with a cadre of highly talented, collaborative, multidisciplinary mentors. PARADIGM will undergo continuous evaluation and quality improvement to ensure long-term success of the trainees. Upon program completion, each trainee will be expected to possess knowledge and skills that will enable them to manage the challenges of evidence generation and clinical use of genomic medicine.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1245/s10434-021-10551-8
发表时间: 2021-10
期刊: Annals of surgical oncology
影响因子: 3.7
作者: [Herremans KM, Cribbin MP, Riner AN, Neal DW, Hollen TL, Clevenger P, Munoz D, Blewett S, Giap F, Okunieff PG, Mendenhall NP, Bradley JA, Mendenhall WM, Mailhot-Vega RB, Brooks E, Daily KC, Heldermon CD, Marshall JK, Hanna MW, Leyngold MM, Virk SS, Shaw CM, Spiguel LR]
通讯作者: Spiguel LR
It begins with the search committee: Promoting faculty diversity at the source.
首先是遴选委员会:从源头上促进教师多样性。
DOI: 10.1016/j.amjsurg.2021.08.027
发表时间: 2022
期刊: American journal of surgery
影响因子: 3
作者: [Arjani,Simran, Tasnim,Sadia, Sumra,Hibba, Zope,Madhushree, Riner,AndreaN, Reyna,Chantal, Henry,Marion, Anand,Tanya]
通讯作者: Anand,Tanya
ASO Visual Abstract: A 5-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
ASO 视觉摘要:乳腺外科医生在 ALND 治疗临床 T1-4N1-3M0 乳腺癌时的 5 年淋巴经验。
DOI: --
发表时间: 2021
期刊: Annals of surgical oncology
影响因子: 3.7
作者: [Herremans,KellyM, Cribbin,MorganP, Riner,AndreaN, Neal,DanW, Hollen,TracyL, Clevenger,Pamela, Munoz,Derly, Blewett,Shannon, Giap,Fantine, Okunieff,PaulG, Mendenhall,NancyP, Bradley,JulieA, Mendenhall,WilliamM, Vega,RaymondBMailhot]
通讯作者: Vega,RaymondBMailhot
DOI: 10.1007/s00423-023-03047-4
发表时间: 2023-08-15
期刊: LANGENBECKS ARCHIVES OF SURGERY
影响因子: 2.3
作者: [Uijterwijk, Bas A., Kasai, Meidai, Lemmers, Daniel H. L., Chinnusamy, Palanivelu, van Hilst, Jony, Ielpo, Benedetto, Wei, Kongyuan, Song, Ki Byung, Kim, Song C., Klompmaker, Sjors, Jang, Jin-Young, Herremans, Kelly M., Bencini, Lapo, Coratti, Andrea, Mazzola, Michele, Menon, Krishna, V, Goh, Brian K. P., Qin, Renyi, Besselink, Marc G., Abu Hilal, Mohammed]
通讯作者: Abu Hilal, Mohammed
17
    Preemptive pharmacogenetic testing in medically underserved populations
    • 批准号:
      10228297
    • 项目类别:
    • 资助金额:
      $75.0万
    • 财政年份:
      2021
    • 负责人:
      Julio David Duarte
    • 依托单位:
    Preemptive pharmacogenetic testing in medically underserved populations
    • 批准号:
      10673936
    • 项目类别:
    • 资助金额:
      $83.29万
    • 财政年份:
      2021
    • 负责人:
      Julio David Duarte
    • 依托单位:
    Improving treatment personalization for pulmonary hypertension associated with diastolic heart failure
    • 批准号:
      9039103
    • 项目类别:
    • 资助金额:
      $17.69万
    • 财政年份:
      2015
    • 负责人:
      Julio David Duarte
    • 依托单位:
    海外基金